gen News

GEN (www.genengnews.com) announced today that it is the proud winner of the Gold FOLIO 2011 Award for Best Online News Coverage in the B2B sector

New Rochelle, NY, September 13, 2011–Mary Ann Liebert, Inc. announces the launch of a journal expansion, Human Gene Therapy Methods, to complement the flagship publication Human Gene Therapy. HGT Methods.

Scientists involved in DNA vaccine research are currently focused on two major issues: the creation of effective delivery systems and the development of more efficient biomanufacturing strategies, reports Genetic Engineering & Biotechnology News.

A move toward smaller and smaller sample sizes is leading to a new generation of mass spectrometry instrumentation, reports Genetic Engineering & Biotechnology News (GEN)

A policy specialist and a healthcare economist both say that the oft-quoted cost of $1.32 billion to bring a new drug to market does not hold up to close scrutiny

The convergence of commercial genomic kits and electronic medical records is helping to drive the healthcare industry’s focus on personalized medicine, reports Genetic Engineering & Biotechnology News (GEN)

Genetic Engineering & Biotechnology News (GEN) will host a Contract Services Summit and Drug Discovery Theater at the Annual BIO International conference in Washington, DC, later this month.

Biotech scientists are working on novel protein kinase inhibitors that are targeting a host of conditions ranging from atherosclerosis to neurodegenerative diseases, reports Genetic Engineering & Biotechnology News (GEN)

Researchers at last month’s AACR conference in Orlando demonstrated that they are intensifying their efforts to identify and validate various types of biomarkers that are detectable in readily accessible bodily fluids

Despite the Nobel Prize-winning discovery of RNA interference (RNAi) over a decade ago and the billions of dollars spent developing therapeutic applications, delivery issues continue to challenge the field

“Intense” just might be the best term to describe the biotech industry’s pursuit of novel biomarkers for new drug discovery and development efforts

Fast Market Research recommends "First Gen Corporation - Overview, Contact Details, Locations, Key executives, Power Plant Information, Business Description and SWOT Analysis" from GlobalData, now available

Recently published research from Datamonitor, "Sandoz International GmbH: PharmaVitae Profile", is now available at Fast Market Research

The mega-mergers of 2009 did not continue into 2010. While the three biggest acquisitions in 2009 each had a price tag of more than $40 billion, only last year’s top purchase got above that mark.

Genetic Engineering & Biotechnology News (GEN) recently co-sponsored a roundtable discussion on new ways to use biological solutions to assist in environment clean-up after manmade or natural disasters

Ready for GEN’s next Cryptogram Challenge? Put your lab skills to the test with the latest online contest based on qPCR. Along with partner Scintellix, LLC and sponsor Bio-Rad Laboratories, Inc., we have launched the Cryptrogram Challenge: qPCR.

Bio-Rad Laboratories, Inc. and Genetic Engineering & Biotechnology News (GEN) today announced that Simon Cocklin, Ph.D. has won a ProteOn™ XPR36 protein interaction array system from Bio-Rad in the ProteOn XPR36 Giveaway Program

Biopharmaceutical firms and other life science organizations are taking definitive steps toward creating greener working environments and developing more sustainable operations, reports Genetic Engineering & Biotechnology News (GEN).

Scientists are turning to a decades-old technique to better understand the physical effects of compression on macromolecules and how it might impact their research in proteomics, mass spectrometry, protein extraction, and tissue investigations

GEN, Scintellix, LLC, and Bio-Rad are proud to announce that the Cryptogram Challenge: Electroporation has been solved. Jodi Bubenik, Ph.D., a molecular biologist, and her husband, Peter Bubenik, Ph.D., a mathematics professor.

Laboratory research and clinical studies are beginning to demonstrate that DNA vaccines can be as effective as traditional vaccines, reports Genetic Engineering & Biotechnology News (GEN).

Genetic Engineering & Biotechnology News has launched another online contest to bring out the puzzle solver in you. Along with partner Scintellix, LLC and sponsor Bio-Rad Laboratories, we are proud to present Cryptogram Challenge: Electroporation.

Researchers around the globe are working on turning microRNAs, over 5,000 of which already have been identified, into novel drugs for a wide range of applications, reports Genetic Engineering & Biotechnology News (GEN).

Increasing numbers of research studies clearly demonstrate that genetics alone cannot explain the diversity of living organisms, reports Genetic Engineering & Biotechnology News (GEN).

Ever imagined what it would be like to be a military decoder? GEN’s (www.genengnews.com) latest contest will definitely grip your imagination.

GREENBioPharma is the sustainability conference of the year. You will learn how to reduce your company’s carbon footprint while lowering costs.

Genetic Engineering & Biotechnology News (GEN) and BioConferences International, Inc., present GREENBioPharma, the first conference exploring the entire range of possibilities and technologies available for sustainable life science organizations.

If thrillers like The Da Vinci Code and The Lost Symbol have enthralled you, then GEN’s latest mind-boggling challenge will certainly stimulate your brain.

The recipients of The 2009 Lasker Awards, announced today, represent the dramatic advances achieved in biotechnology research that have led to a revolutionary cancer treatment and the tremendous promise of stem cell therapy for regenerative medicine.

Next-Generation Sequencing (NGS) technologies are not only beginning to supplant traditional Sanger sequencing methodology but are also giving DNA microarrays a run for the money as well, reports Genetic Engineering & Biotechnology News (GEN)

If you like solving puzzles and are looking to test your genius, Genetic Engineering & Biotechnology News' (GEN) latest contest will stimulate your brain.

Scientists say they are forging ahead in developing replacements for petrochemical fuels that will be cost-competitive and renewable while having a minimal impact on the environment, reports Genetic Engineering & Biotechnology News (GEN).

It is widely used ed for use infor warehousing, parking, distribution, shop floor, in harsh manufacturing or processing environments and outdoors. This RFID reader/writer is an ideal solution for applications where no host PC is connected.

Scientists around the world are accelerating their efforts to develop a vaccine against the H1N1 influenza virus (Swine flu) as rapidly as possible, reports Genetic Engineering & Biotechnology News (GEN).

The American Civil Liberties Union action in filing a lawsuit yesterday against Myriad Genetics is going to lead to one of the most important legal battles in the history of biotechnology, asserts Genetic Engineering & Biotechnology News (GEN).

This passive RFID tag meets all endurance requirements in terms of heat, pressure and chemical resistance, and is used for contactless tracking of garments in the textile rental and laundry industries.

Although Boston, San Francisco, San Diego, and Cambridge (U.K.) are always near the top of most biotechnology cluster lists, other areas around the world are starting to pop up on the life science radar screen

A novel technique for carrying out gene-expression profiling is set to challenge the market dominance of the current, widely used methodology, reports Genetic Engineering & Biotechnology News (GEN).

The reader, which ships with a software development kit (SDK), provides a convenient and easy way to develop projects.

GAO RFID Asset Tracking's Gen 2 RFID Reader is a robust, easy to use EPC compliant reader that is suitable for supply chain or manufacturing and asset management applications.

While the Bernard Madoff Ponzi scheme led to the collapse of the Picower Foundation, a major benefactor for life science research, many bioindustry observers view the fallout from the scandal as a minor consequence in the larger economic picture.

GAO RFID Asset Tracking recommends its portable handheld RFID reader/writer EU865-869. This multi-protocol instrument is designed for commercial use, and it has been successfully deployed for field service in warehousing, supply-chain and retail POS

The disposable bioprocessing market has moved far beyond plastic bags for buffer preparation toward a range of products for cell culture and upstream and downstream operations, reports Genetic Engineering & Biotechnology News (GEN).

The blood-brain barrier (BBB) remains a major obstacle to the successful delivery of drugs to treat central nervous system (CNS) disorders, reports Genetic Engineering and Biotechnology News (GEN)

Biotechnology companies are building on what they have learned about microfluidics techniques over the past decade and are expected to drive this market toward $1.9 billion in three years

Theodosius Dobzhansky, the late great geneticist and evolutionary biologist, said it best: “Nothing in biology makes sense except in the light of evolution.”

Researchers are taking a closer look at the phosphoinositide 3-kinase (PI3-kinase) pathway as studies continue to demonstrate that inhibiting this biological route suppresses tumor growth, reports Genetic Engineering & Biotechnology News (GEN).

Biotech scientists increasingly are applying genomics technologies to toxicology research to better understand the effects of novel drug candidates on a variety of organ systems.

If you thought the Da Vinci Code was exciting, try the GEN Microarray Challenge. Genetic Engineering & Biotechnology News (GEN) along with partner, Scintellix, and sponsor, Agilent, are proud to bring you the puzzle that’s sure to make you think.

Systems biology scientists from diverse areas of research are developing a range of methods to model pathways, interpret data, and derive therapeutic targets from biological networks, reports Genetic Engineering and Biotechnology News (GEN).